Corrigendum to "Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease" [Cell. Immunol. 327 (2018) 77-82]
1 Institute of Experimental Medicine, Saint Petersburg, Russian Federation; Peter the Great St Petersburg Polytechnic University, Saint Petersburg, Russian Federation; ITMO University, Saint Petersburg, Russian Federation.
2 Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, Russian Federation.
3 Institute of Human Brain, Russian Academy of Sciences, Saint Petersburg, Russian Federation.
4 Institute of Experimental Medicine, Saint Petersburg, Russian Federation.
5 Karolinska Institute, Department of Medical Biochemistry & Biophysics, Stockholm, Sweden; Faculty of Mechanics and Mathematics, Lomonosov Moscow State University, Moscow, Russian Federation. Electronic address: alexandra.beradotte@gmail.com.